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Pharmacist-led influenza vaccination services in residential aged care 
homes: a pilot study  
Abstract  
Objectives: The feasibility of pharmacist-led influenza vaccination services in residential aged 
care homes has not previously been studied. The primary objective of this pilot study was to 
evaluate this feasibility. The secondary objective was to assess the effect on employee 
vaccination rates.  
Methods: An in-house pharmacist-led vaccination service was implemented at a single site in 
2017. De-identified employee influenza vaccination records at this site for 2016 and 2017 were 
compared to assess the change in vaccination rate.  
Results: The residential care pharmacist administered 37% of all influenza vaccinations to 
employees (n=78) in 2017. Between 2016 and 2017 there was a significant improvement in the 
employee vaccination rate at the site (46.5% vs. 69.2%, p<0.01). 
Conclusion: It is feasible for pharmacists to administer influenza vaccinations to employees 
in residential aged care. The flexibility of an in-house pharmacist improves accessibility and 
can therefore promote uptake of influenza vaccination by employees.  
Keywords Aged care, employees, influenza, nursing homes, pharmacists, preventive 
programs, vaccination. 
Impact statement 
The feasibility of pharmacist-led influenza vaccination services in residential aged care homes 
has not previously been reported. Findings of this pilot study indicate that these services are 
feasible and can significantly improve the uptake of influenza vaccination by employees, 
warranting further investigation as a potential national strategy to address influenza-related 





Influenza is the leading cause of vaccine-preventable death and hospitalisations due to 
notifiable communicable disease in Australia [1]. Older adults living in residential aged care 
homes (RACHs) are particularly susceptible to influenza-associated morbidity and mortality 
due to increased frailty, the presence of multiple chronic medical conditions, and impaired 
response to anti-viral drug therapy [2]. The annual number of influenza-related deaths in 
Australia was the highest ever recorded in 2017, with 91% of influenza-related deaths recorded 
in people aged over 65 years [3]. RACHs are closed communities which promote the rapid 
transmission of the influenza virus between residents, increasing the risk of clinical infection 
[4]. Furthermore, RACH residents are more likely to require hospitalisation due to influenza 
than individuals residing in the community [5]. 
 The Australian National Health and Medical Research Council recommends annual 
influenza vaccination as the single most important intervention for preventing influenza [6]. 
RACH employees work in close contact with multiple residents daily and are an important 
source of transmission if not vaccinated [4,7,8]. Annual influenza vaccination is recommended 
for all RACH employees, due to their close interaction with older, frail residents [8]. RACHs 
with an employee vaccination rate above 75% report lower frequencies of influenza outbreak 
compared with homes with lower rates of vaccine uptake amongst employees [9]. A 
vaccination rate of 95% of all residents and employees prior to the influenza season is 
recommended to induce herd immunity and protect residents [9].   
 Annual influenza vaccination is not currently mandatory for RACH employees in 
Australia and uptake is at the discretion of the individual [9]. Consequently, the RACH 
employee influenza vaccination rates are suboptimal, with less than 4% of RACHs reporting 
that they have achieved the recommended vaccination rate of 95% [9]. Approximately 43% of 
RACHs have influenza vaccination rates at less than 50% [9]. Employee vaccination rates 
within RACHs in the Australian Capital Territory (ACT) are particularly low, with reported 
vaccination rates as low as 28% [4]. Reasons cited by RACH employees for not receiving 
annual influenza vaccination include: concerns about vaccine side effects, perceived lack of 
vaccine efficacy or necessity, vaccination not recommended by the employer/organisation, 
affordability, inconvenience, and accessibility [4,8,10].  
 Some of these barriers may be circumvented through flexible on-site employee 
vaccination programs offered at no cost by RACH organisations. Approximately 86% of 
Australian RACHs report having an established program which provides vaccines to 
employees [9]. However, many on-site programs are outsourced to external providers who 
offer a limited number of fixed-duration vaccination clinics for employees, restricting 
opportunities for shift workers. Given the largely casualised and part-time nature of the RACH 
workforce in Australia [11], offering a vaccination program with fixed availability for a limited 
duration may be unsatisfactory for employees working outside of usual business hours, who 
might also find it difficult to visit their general practitioner (GP). Almost 10% of RACHs do 
not offer any on-site vaccinations but encourage employees to obtain the vaccine from their 
GP [9].  
 The Australian population is aging and demand for RACH placements is increasing 
[12]. Therefore, identifying strategies for optimising vaccination rates for RACH employees to 
protect residents from influenza is of growing importance. Pharmacists have been permitted to 
vaccinate people against influenza in the Australian community since 2015 [13]. The rationale 
for this initiative was to improve accessibility for members of the community who have 
difficulty accessing vaccination through their GP or employer, as pharmacies tend to have 
extended business hours [13]. Similarly, having an on-site pharmacist within RACHs, available 
to administer influenza vaccinations to employees as a component of their role, may increase 
flexibility and convenience for the provision of vaccination. Further, pharmacists are 
appropriately qualified to educate employees on the risks and benefits of vaccination including 
potential side effects, and the importance of receiving vaccination to protect residents and 
themselves.  
 To date, the effect of pharmacist-led vaccination services on RACH employee 
vaccination rates has not been explored. The primary objective of this pilot study was to 
evaluate the feasibility of an in-house influenza vaccination service provided by a pharmacist. 
The secondary objective was to evaluate the effect of the service on RACH employee influenza 
vaccination rates.  
Methods 
The pilot study was part of a broader trial exploring the feasibility of integrating a residential 
care pharmacist (RCP) into an established team within a RACH located in the ACT [14]. The 
 RCP provided influenza vaccinations to both employees and residents as part of the broader 
trial addressing multiple quality use of medicines components.  
 A vaccination-accredited RCP was piloted for six months from April 20th, 2017 to 
October 13th, 2017. The RCP was employed part-time, two consecutive days per week (0.4 
full time equivalent) for the duration of this period. Employee influenza vaccination registers 
for 2016 and 2017 were maintained by the clinical care manager, documenting employees who 
had received a vaccine on-site or provided evidence from their external provider, such as a GP. 
The registers included all full-time, part-time and casual nursing, care, administration, 
cleaning, and catering employees at the RACH. Deidentified data were provided to the 
principal investigator for analysis at the end of the RCP trial period. The RCP had documented 
the number of vaccinations provided to employees and the time spent performing this activity 
on each occasion. The study site had a total of 71 employees in 2016 and 78 employees in 
2017.  Self-reported data from  21 RACHs with known vaccination rates in the ACT was  
provided by the Australian Aged Care Quality Agency [15]. 
 Fisher’s exact test was used to compare employee vaccination rates in 2016 and 2017 
at the study site. A one-sample proportions test compared the vaccination rate at the study site 
in 2017 with the state average self-reported rate of vaccinations in 2017. All analyses were 
conducted using SPSS Statistics version 22.0 (IBM, Armonk, NY, USA) and p-values of <0.05 
were considered statistically significant. This research was approved by the University of 
Canberra Human Research Ethics Committee (HREC 16-244). 
Results  
Of the total number of 78 employees at the RACH in 2017, 54 (69.2%) received an influenza 
vaccine. The employee influenza vaccination rate improved significantly from 46.5% in 2016 
(Fisher’s exact p<0.01). The RCP spent a total of 3.4 hours administering influenza vaccines 
to 20 (37%) employees in 2017. The difference between the employee vaccination rate at the 
study site (69.2%) and the ACT state average in 2017 (54.2%) was significant (z = 2.66, 
p<0.01) [15].  
 No adverse events were recorded in association with the pharmacist-administered 
vaccines. The RCP also recorded administration of vaccines to two residents at the study site 
who were unable to obtain the vaccine from their GP, and four employees from a separate 
RACH in nearby proximity to the study site.  
Discussion 
This is the first Australian study to investigate an in-house pharmacist-led influenza 
vaccination service in residential aged care. The findings indicate that it is feasible to include 
an in-house pharmacist in RACHs, who can provide a flexible option to administer influenza 
vaccinations to fellow employees. While registered nurses working within the RACH could 
theoretically have administered influenza vaccines to fellow employees, it was noted that they 
were fully occupied on their primary duty of providing time-critical clinical care activities 
directed at residents.  
The pharmacist-led vaccination service contributed to an increased vaccination rate of 
22.7%, resulting in a vaccination rate of 69.2% in 2017. This compared favourably and 
significantly with the average self-reported rate of 54.2% for ACT RACHs. The increased 
uptake of influenza vaccination by employees was facilitated by the implementation of an in-
house program with the capacity to administer ad-hoc vaccinations, rather than at fixed clinic 
or appointment times available through external providers. Convenience and accessibility are 
two leading barriers to RACH employee uptake of influenza vaccination cited in the literature 
[4,8,10].  
This was a single-site pilot study, without a control site. Another limitation was the 
part-time nature of the RCP role, who was only on-site at the RACH two consecutive days per 
week. This limited the accessibility of vaccination by the RCP for employees working 
exclusively on weekends, evening shifts and part-time on days where the RCP was not present. 
Further, the timing of influenza vaccination is recommended to commence in March and April 
once the annual vaccine is available and prior to peak influenza season starting from June [2]. 
The RCP did not commence employment until late April, limiting opportunities for providing 
employee education and promotion of the service to overcome perceived lack of vaccine 
efficacy or necessity as a barrier to uptake [4,8,10]. These issues may have contributed to the 
final employee vaccination rate in 2017 still being below the recommended vaccination rate of 
95% [9]. 
Additionally, the acceptability of this service from the perspective of the RACH 
employees was not formally evaluated. Finally, this service was feasible under ACT legislation 
where pharmacists are not restricted to administering influenza vaccinations within a 
 community pharmacy [16]. Legislation changes would be required nationally for this model to 
be successful in other states and territories.  
Conclusion 
This pilot study demonstrated that it is feasible to include pharmacists as part of in-house 
influenza vaccination programs in RACHs. The implementation of the service significantly 
increased the uptake of influenza vaccination by RACH employees. A larger trial, 
incorporating a comprehensive assessment of acceptability, clinical outcomes and cost-
effectiveness, is warranted. 
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